Automated breast ultrasound systems sales will rise through 2036, driven by breast cancer screening at a 68.7% share, supported by growing adoption as a supplemental screening tool for women with dense breast tissue. Automated breast ultrasound system holds a 63.4% share. The market is set to reach USD 5.9 billion by 2036.